08 / HEALTHCARE 4.0 ESSENTIAL
Measure, predict, act. Today's healthcare does the first two well. GRBM fills the empty third step: the material that actually carries out recovery inside the body.
In plain words
Today we measure our bodies with health check-ups and smartwatches, and AI lets us look ahead at our future health. It is a lot like a weather forecast. But knowing that it will rain does not keep you dry if you have no umbrella.
In health, that umbrella — something that actually restores the body — has been missing. HEALTHCARE 4.0, represented by AI, big data and wearables, has the data layer, but it lacks a bio-core material that can actually change the metabolism and immunity inside the body.
GRBM is an eco-bio food made by plants and the beneficial bacteria living inside them. Because it is food, not medicine, anyone can take it every day, and the body recognizes it at once. That is why I am convinced that GRBM must be invested in and advanced as the core bio-material of HEALTHCARE 4.0 services, and that it is indispensable to completing the HOLON concept.
MEASURE · PREDICT · ACT
Check-ups and smartwatches measure the body — what today's healthcare does well
AI forecasts future health — what today's healthcare does well
GRBM lets the body actually recover — the place GRBM fills
According to the World Health Organization, three in four deaths worldwide are caused by chronic (non-communicable) diseases; by 2030 one in six people will be 60 or older, and by 2050 the population aged 60+ will reach 2.1 billion. Chronic disease and ageing cannot be explained by a single cause or a single organ. I see them as the result of metabolism, immunity and microbes being shaken together — an imbalance of the whole Holobiont. So my goal is one thing: healthy life expectancy = life expectancy.
HEALTHCARE 1.0 → 4.0
| Stage | Focus | Limit |
|---|---|---|
| 1.0 · Physical care | Face-to-face consultation and basic physical care | After-the-fact response |
| 2.0 · Machine care | Surgery and medical devices | Symptom suppression, side effects |
| 3.0 · Patient-centred | Medical services centred on the patient | More measurement, too few means of recovery |
| 4.0 · Connected care | IoT, big data, cloud, digital twins — measuring and predicting | No bio-core material that actually changes the body |
| + Execution layer | GRBM — acting inside the body | The developer's added interpretation |
| Conventional digital health | HEALTHCARE 4.0 as the developer sees it | |
|---|---|---|
| What it does | Measure, record, predict | Measure and predict, plus an intervention that acts inside the body |
| Intervention | Drugs and procedures added disease by disease | GRBM that changes the cells' metabolic environment — at the level of the whole body |
| Data | Vital signs and medical records | Genome, microbiome, metabolome, lifestyle — and the response to GRBM protocols |
| Form | Hospitals and apps | Food × Medicine — as close as food, aiming at a response as quick as medicine |
| Goal | Managing disease | Healthy life expectancy = life expectancy |
The 1.0–4.0 stages follow the academic literature; the execution layer on the far right is the developer's added interpretation.
TWO KINDS OF METABOLITES
| Ordinary metabolite | GRBM metabolome | |
|---|---|---|
| Where it forms | In the digestion of food | Through Green Red BIO metabolization |
| Absorption | Absorbed after digestion | Absorbed directly, without digestion |
| Use by cells | Requires enzyme activity | Used at once through the information of bound genetic material |
| Energy metabolism | Butyrate pathway | Lactate–acetate pathway |
| What remains | Ageing by-products such as free radicals | No separate ageing by-products |
This mechanism already exists in our bodies. An embryo that has only just begun to form cannot yet run its own enzyme activity, so the mother must supply metabolites its cells can recognize and use directly. In the mother's body, those metabolites are made with the help of mutualistic lactic acid bacteria (ELAB) and passed to the fetus. GRBM reproduces this maternal mechanism outside the body, with plants and their bacteria, to bring it to everyone regardless of age.
The two fields are not competitors. They are a sequence.
ECOLOGICAL SYSTEMS BIOLOGY
Chemical drugs carry the possibility of isomers, and isomers can interfere with intrinsic biological function. In its 1992 guidance the US FDA noted that enantiomers can differ in pharmacokinetics and pharmacology, and required the isomeric composition of new drugs to be characterized. So a purely molecular-biological approach always leaves the chance that solving one phenomenon creates another side effect. Over 20 years of research I built the ecological systems biology methodology to address this problem at its root.
| Molecular-biological approach | Ecological systems biology approach | |
|---|---|---|
| Unit of view | Molecules and targets | The whole person — one integrated organism (Holobiont) |
| Material | Synthetic molecules — possible isomers | Metabolically converted material — no chemical-synthesis step that creates isomers |
| How it works | Blocks or stimulates a specific target | Fills cells' missing or faulty information and supplies the right bio-materials |
| Result | One problem solved, another side effect possible | Ecological recovery in which the body improves itself |
| Field | General medicine | Eco-bio science |
Remove the process that creates isomers — heat-free, chemical-free metabolic conversion
Fill cells' missing or faulty information — External miRNA
Supply the right bio-materials — the GRBM metabolome
Lead ecological self-improvement — recovery of the Holobiont
On the recovered body, drugs improve and supplement function
FIVE REASONS
Metabolic realignment has a 12-week sequence and signals such as abdominal-aortic pulsation, thymic reactivation and skin temperature. Now that microRNA sequencing and Treg/FOXP3 measurement are standard tools, it can be measured and modelled in the same language.
Metabolized protein supports vertical inheritance (VGT), the plant-lactobacilli ecosystem supports horizontal inheritance (HGT), and the GRBM metabolome supports the dialogue between them. One input reaches the whole Holobiont.
It was designed from the start as an eco-bio food that babies and pregnant women, the elderly and the frail can all eat and drink. Only an intervention that comes to the daily table can become lifelong care.
VPMI lets the lactobacilli inside a plant metabolize that plant directly, without heat, chemicals, salt or sugar. With no chemical-synthesis step there is no process cause for isomers, and one standard catalyst has converted 60 plant species.
It holds a plant's genome, the microbes that live with it and the metabolome they make in a single material. Human metabolic health and the recovery of the land are achieved in the same process.
| Year | Prize-winning work | Where GRBM meets it |
|---|---|---|
| 2023 | Discoveries on nucleoside base modifications that enabled mRNA vaccines | Treating RNA as an "active material" — a heat-free process that preserves the state of genetic material |
| 2024 | The discovery of microRNA and its role in post-transcriptional gene regulation | The External miRNA hypothesis — extracellular miRNA bound in GRBM |
| 2025 | Discoveries on peripheral immune tolerance — Treg and FOXP3 | The metabolic realignment hypothesis — thymic reactivation and Treg re-education within 12 weeks |
The Nobel Prizes do not prove GRBM's effects. Proving that connection is my next task.
To be used every day for a lifetime, something must be safe, usable by anyone and not rejected by the body. Chemically made substances carry the risk of isomers and side effects and do not suit lifelong daily intake. GRBM meets these conditions because it is food made by plants and their beneficial bacteria, without heat or chemicals.
Prevent substances the body cannot accept — no heat, no chemicals
Supply the information cells lack — External miRNA
Provide nutrition the body can use at once — metabolized nutrition
On a recovered body, medicine does its own job
Statistics: Statistics Korea, 2024 Life Tables; World Health Organization (WHO). Healthcare stages: a systematic review of Healthcare 4.0 (International Journal of Information Management Data Insights, 2022). Interpretations and observations: Source: research by the developer (Wooyoung Nam). GRBM does not claim to diagnose, treat or prevent disease.
PARTNERSHIP · INVESTMENT
After signing an NDA you can review the materials, then verify the original records and the process in person during on-site due diligence in Uljin, Gyeongsangbuk-do, Korea.
